Assist. Prof. Dr. Joanna Bojarska | Cancer Biotechnology | Best Researcher Award
Chemistry Department at Technical University of Lodz | Poland
Assist. Prof. Dr. Joanna Bojarska is a dedicated researcher and academic at the Technical University of Lodz in Poland, where she works within the Department of Chemistry. Her expertise lies in supramolecular chemistry, particularly the study of short peptides and modified amino acids that hold immense promise in biomedical research. With a strong publication record and significant citation impact, she has established a reputation for advancing knowledge in structural and functional peptide chemistry. She is widely recognized for her contributions to understanding the therapeutic potential of cyclic and pseudocyclic peptide scaffolds, and her scientific career reflects an enduring commitment to both fundamental research and applied biomedical innovation.
Profile
Orcid | Scopus | Google scholar
Education
Assist. Prof. Dr. Joanna Bojarska has pursued a rigorous academic path that highlights her devotion to chemical and biomedical sciences. She has achieved advanced qualifications in the exact and natural sciences, supported by her extensive work on supramolecular chemistry of short peptides and modified amino acids. Her educational journey was further enriched by international training opportunities, including specialized biochemical studies that strengthened her interdisciplinary expertise. These experiences have not only shaped her technical competence but also positioned her as a global thinker capable of integrating diverse perspectives in research. Her academic achievements were later complemented by her progression into professorial roles, affirming her place as a recognized leader in her discipline.
Experience
Her professional career has been closely tied to the Technical University of Lodz, where she has contributed extensively to research and education. As a researcher, she has led and participated in numerous projects addressing innovative approaches to peptide-based supramolecular systems, drug and vaccine design, and the structural exploration of therapeutic scaffolds. She has successfully combined experimental investigations with computational modeling, producing comprehensive insights into the function and design of bioactive compounds. In addition to her research responsibilities, she has taken on roles in teaching and mentoring, ensuring that her expertise also benefits the academic growth of students and colleagues. Her involvement in European collaboration projects, particularly through academic mobility initiatives, further reflects her international engagement and commitment to cross-border scientific exchange.
Research Interest
The central theme of her research is supramolecular chemistry, with a specific interest in the structural and functional properties of short peptides. Assist. Prof. Dr. Joanna Bojarska has focused extensively on cyclic and pseudocyclic motifs, which are highly relevant in therapeutic applications, including anticancer and neuroprotective strategies. Her studies often bridge the gap between chemistry and medicine, emphasizing the potential of peptides in targeting G protein-coupled receptors and other pharmacological pathways. She applies both experimental crystallographic approaches and advanced computational techniques to investigate the stability, interactions, and biological activity of peptide scaffolds. Her work contributes to the smart design of ligands and theranostic agents, aligning scientific curiosity with clinical applicability.
Award
Throughout her career, she has been honored with multiple recognitions that highlight her impact as both a researcher and educator. She has received several Rector’s Awards for her achievements in scientific research, excellence in teaching, and popularization of science. Her contributions have also been acknowledged at the international level, with nominations for highly respected honors such as the Horizon Prizes for Education and the Protein and Peptide Science Award. Beyond awards, her research leadership is reflected in successful management of national and European grants, including projects aimed at developing innovative biomedically relevant peptide systems and sustainable solutions in food and health sciences. Her ability to translate research ideas into tangible results has also led to patent recognition for peptide-based supramolecular systems with therapeutic potential.
Publication Top Notes
A global review on short peptides: frontiers and perspectives.
Year: 2021
Citations: 389
Cyclic Dipeptides: The Biological and Structural Landscape with Special Focus on the Anti-Cancer Proline-Based Scaffold.
Year: 2021
Supramolecular synthon hierarchy in cyclopropyl-containing peptide-derived compounds.
Year: 2022
Structural and biofunctional insights into the cyclo(Pro-Pro-Phe-Phe-) scaffold from experimental and in silico studies: Melanoma and beyond.
Year: 2022
An experimental and computational investigation of the cyclopentene-containing peptide-derived compounds: focus on pseudocyclic motifs via intramolecular interactions.
Year: 2024
Short Peptides: Novel Supramolecular Synthons for Designing Anticancer Theranostics.
Year: 2023
Drug and vaccine design platform as an innovative research and teaching tool.
Year: 2022
Conclusion
In conclusion, Assist. Prof. Dr. Joanna Bojarska represents the profile of a modern scientist who skillfully balances research, teaching, and innovation. Her career reflects a seamless integration of supramolecular chemistry with biomedical applications, emphasizing the translational potential of short peptides as therapeutic agents. Through her extensive publications, funded projects, and international collaborations, she has contributed to advancing the structural understanding of bioactive compounds while also engaging in projects of societal and educational significance. Her scientific achievements, combined with her dedication to fostering academic growth, position her as a leading figure in the interdisciplinary space where chemistry meets medicine. Her continuing work promises to inspire new discoveries and broaden the scope of peptide research in addressing global health challenges.